144 related articles for article (PubMed ID: 6277654)
1. Difference in tolerance development of hypothermia and pentobarbital-induced sleep prolongating effect of 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol in mice.
Watanabe K; Narimatsu S; Yamamoto I; Yoshimura H
Eur J Pharmacol; 1982 Jan; 77(1):53-6. PubMed ID: 6277654
[TBL] [Abstract][Full Text] [Related]
2. Cross-tolerance development to the prolongation of pentobarbitone-induced sleep by delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
Watanabe K; Narimatsu S; Yamamoto I; Yoshimura H
J Pharm Pharmacol; 1987 Nov; 39(11):945-7. PubMed ID: 2892923
[TBL] [Abstract][Full Text] [Related]
3. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
[TBL] [Abstract][Full Text] [Related]
4. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
Watanabe K; Yamamoto I; Yoshimura H
Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407
[TBL] [Abstract][Full Text] [Related]
5. [Sex difference in the effects of delta 9-tetrahydrocannabinol and cannabidiol on pentobarbital-induced sleeping time and hepatic microsomal drug metabolizing enzyme systems in mice].
Hamajima K; Watanabe K; Narimatsu S; Tateoka Y; Yamamoto I; Yoshimura H
Yakugaku Zasshi; 1983 Dec; 103(12):1289-97. PubMed ID: 6330340
[No Abstract] [Full Text] [Related]
6. Synthesis and pharmacological activities in mice of halogenated delta 9-tetrahydrocannabinol derivatives.
Usami N; Kobana K; Yoshida H; Kimura T; Watanabe K; Yoshimura H; Yamamoto I
Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1462-7. PubMed ID: 9775440
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of the effect of delta 9-tetrahydrocannabinol on barbiturate sleeping time by specific active immunization.
Giusti GV; Chiarotti M; Vigevani F
Drug Alcohol Depend; 1980 Mar; 5(3):185-7. PubMed ID: 6243536
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacological effects of tetrahydrocannabinols and their 11-hydroxy-metabolites in mice.
Watanabe K; Kijima T; Narimatsu S; Nishikami J; Yamamoto I; Yoshimura H
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2317-9. PubMed ID: 2177683
[TBL] [Abstract][Full Text] [Related]
9. Comparison in mice of pharmacological effects of delta 8-tetrahydrocannabinol and its metabolites oxidized at 11-position.
Watanabe K; Yamamoto I; Oguri K; Yoshimura H
Eur J Pharmacol; 1980 Apr; 63(1):1-6. PubMed ID: 6247159
[No Abstract] [Full Text] [Related]
10. Pharmacological activities in the mouse of delta 9-tetrahydrocannabinol metabolites oxidized at the 8-position.
Narimatsu S; Matsubara K; Shimonishi T; Watanabe K; Yamamoto I; Yoshimura H
Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):392-5. PubMed ID: 2988803
[No Abstract] [Full Text] [Related]
11. Cannabichromene and delta 9-tetrahydrocannabinol: interactions relative to lethality, hypothermia and hexobarbital hypnosis.
Hatoum NS; Davis WM; Elsohly MA; Turner CE
Gen Pharmacol; 1981; 12(5):357-62. PubMed ID: 6269951
[No Abstract] [Full Text] [Related]
12. Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice.
Thorat SN; Bhargava HN
Eur J Pharmacol; 1994 Jul; 260(1):5-13. PubMed ID: 7957626
[TBL] [Abstract][Full Text] [Related]
13. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
Lawrence DK; Pertwee RG
Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
[TBL] [Abstract][Full Text] [Related]
14. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
Haavik CO; Hardman HF
Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
[No Abstract] [Full Text] [Related]
15. 9 alpha, 10 alpha-epoxyhexahydrocannabinol formation from delta 9-tetrahydrocannabinol by liver microsomes of phenobarbital-treated mice and its pharmacological activities in mice.
Narimatsu S; Yamamoto I; Watanabe K; Yoshimura H
J Pharmacobiodyn; 1983 Aug; 6(8):558-64. PubMed ID: 6315913
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic delta 9-tetrahydrocannabinol administration on schedule-controlled behavior of pigeons: cross-tolerance to pentobarbital and barbital.
Chait LD; Brocco MJ; McMillan DE
Psychopharmacology (Berl); 1981; 75(1):1-4. PubMed ID: 6272342
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro properties of anti-delta 9-tetrahydrocannabinol antibody.
Chiarotti M; Giusti GV; Vigevani F
Drug Alcohol Depend; 1980 Mar; 5(3):231-3. PubMed ID: 6243537
[TBL] [Abstract][Full Text] [Related]
18. Systematic assessment of tolerance to pentobarbital by pellet implantation.
Ho IK
J Pharmacol Exp Ther; 1976 Jun; 197(3):479-87. PubMed ID: 932988
[TBL] [Abstract][Full Text] [Related]
19. The effects of thyrotropin releasing hormone on pentobarbital tolerance.
Bhargava HN
Eur J Pharmacol; 1981 Jun; 72(1):63-8. PubMed ID: 6790297
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to the hypothermic and aggression-attenuating effect of delta 8 - and delta 9 - tetrahydrocannabinol in mice.
Ten Ham M; De Jong Y
Eur J Pharmacol; 1974 Sep; 28(1):144-8. PubMed ID: 4473345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
